Pediatric Radiology Associates
Pediatrics
Dr. Daniel W. Young, MD
|
|
Give Review
Daniel Young works in the field of Pediatrics. He attended Loma Linda University School of Medicine. Doctor Daniel W. Young, MD is a published doctor and has 61 publications published. The lastest was: 'Surgical and Anesthetic Management of a Mediastinal Fatty Tumor: Lipoblastoma.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Surgical and Anesthetic Management of a Mediastinal Fatty Tumor: Lipoblastoma.
- Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-d-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts.
- Effects of Parkinson's disease on optic flow perception for heading direction during navigation.
- Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI:...
- Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington's disease.
- Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹?F-FAHA.
- Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: a retrospective study.
- Invasive Giant Prolactinoma Presenting as a Nasal Polyp.
- Risk Factors for Temporomandibular Joint Arthritis in Children with Juvenile Idiopathic Arthritis.
- Genomic promoter occupancy of runt-related transcription factor RUNX2 in osteosarcoma cells identifies genes involved in cell adhesion and motility.
- Brain cavernomas associated with en coup de sabre linear scleroderma: two case reports.
- Bookmarking the genome: maintenance of epigenetic information.
- An architectural genetic and epigenetic perspective.
- Corticosteroid-induced spinal epidural lipomatosis in the pediatric age group: report of a new case and updated analysis of the literature.
- Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.
- Development of a targeted gene vector platform based on simian adenovirus serotype 24.
- Architectural epigenetics: mitotic retention of mammalian transcriptional regulatory information.
- Mitotic bookmarking of genes: a novel dimension to epigenetic control.
- Subnuclear localization and intranuclear trafficking of transcription factors.
- Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer.
- Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds.
- Effects of optic flow speed and lateral flow asymmetry on locomotion in younger and older adults: a virtual reality study.
- Transcription-factor-mediated epigenetic control of cell fate and lineage commitment.
- Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: implications for biological control in cancer.
- Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT.
- The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
- Impact of optic flow perception and egocentric coordinates on veering in Parkinson's disease.
- Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors.
- Genetic and epigenetic regulation in nuclear microenvironments for biological control in cancer.
- Extensive pulmonary laceration in pediatric trauma.
- Phenotypic transcription factors epigenetically mediate cell growth control.
- Integrating high-content screening and ligand-target prediction to identify mechanism of action.
- In situ nuclear organization of regulatory machinery.
- Chromatin immunoprecipitation assays: application of ChIP-on-chip for defining dynamic transcriptional mechanisms in bone cells.
- Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint.
- Nuclear microenvironments in biological control and cancer.
- Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells.
- Organization of transcriptional regulatory machinery in nuclear microenvironments: implications for biological control and cancer.
- Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2.
- Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2.
- Permanent exocrine and endocrine pancreatic deficiency following hemolytic uremic syndrome.
- Networks and hubs for the transcriptional control of osteoblastogenesis.
- Outcome of extremely preterm infants randomized at birth to different PaCO2 targets during the first seven days of life.
- Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2.
- Combinatorial organization of the transcriptional regulatory machinery in biological control and cancer.
- Organization of transcriptional regulatory machinery in osteoclast nuclei: compartmentalization of Runx1.
- The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.
- SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
- The dynamic organization of gene-regulatory machinery in nuclear microenvironments.
- Intranuclear trafficking: organization and assembly of regulatory machinery for combinatorial biological control.
- Quantitative signature for architectural organization of regulatory factors using intranuclear informatics.
- Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression.
- Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation.
- Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells.
- Nuclear microenvironments support physiological control of gene expression.
- Tumor suppressor pRB functions as a co-repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription.
- Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation.
- Intranuclear organization of RUNX transcriptional regulatory machinery in biological control of skeletogenesis and cancer.
- Intranuclear trafficking of transcription factors: Requirements for vitamin D-mediated biological control of gene expression.
- Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
Schools
Loma Linda University School Of Medicine
Loma Linda University Hospital
Loma Linda University Medical Center
ChildrenS Hospital Medical Center
Doctors Specialties
- Nuclear Radiology
- Pediatric Radiology
- Pediatrics
Accepted Insurances
- Aetna
- Amerigroup (Wellpoint)
- Blue Cross Blue Shield
- Dental Blue 100/200/300
- CareSource
- CHAMPVA
- Cigna
- Commercial Insurance Company
- Coventry Health Care
- Golden Rule
- GEHA
- HealthSmart
- Humana
- Kaiser Permanente
- Locals (any local)
- Mail Handlers Benefit Plan (MHBP)
- Medica
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Planned Administration Inc
- Principal Life
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
- Wells Fargo Insurance
Education
-
Boston Children's Hospital -
Loma Linda University -
Loma Linda University School of Medicine
Hospital
-
University of Alabama Hospital -
Brookwood Medical Center -
Children's of Alabama
Drug Facts
| NPI NUMBER | 1659376580 | |
| NPPES Provider LastName | YOUNG | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 352331711 | |
| NPPES Provider State | AL | |
| Specialty Description | Diagnostic Radiology | |
| Total Claim Count | 12.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1659376580 |
| Last Name Of The Provider | YOUNG |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Peily Soong, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn S. Ashworth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melisa M. Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oliver H. Muensterer, MD |
|
|
Dr. Tracy F. Tindle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard S. Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arnold C. Merrow Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yoginder N. Vaid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marjorie L. White, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart A. Royal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nowice A. Trexler, MD |
|
|
Dr. Manish N. Patel, MD |